Pro-inflammatory M1 macrophages involved in immune responses accelerate the progression of melanoma through the extracellular ...

A proof-of-concept study opens up an avenue for treating solid tumours that express low levels of a target antigen.

A Phase 1 trial testing TG Therapeutics' CAR T-cell therapy azer-cel in progressive forms of MS is now recruiting across eight U.S. sites.

Promega Corporation is launching a new live-cell target engagement platform that could close a long-standing gap between biochemical and cellular assays for understudied or difficult-to-interrogate ...

Researchers hope to undertake clinical studies in multiple cancers, including ovarian cancer, glioblastoma, and others.

Long overlooked in the field of musculoskeletal study, the tendon is a highly complex anatomical structure that triggers a dynamic but mysterious cellular response when it's injured. In a new study in ...

A new method can produce specially designed proteins that can arm T cells to attack cancer cells. Precision personalized cancer treatment on a larger scale has come a step closer after researchers ...

Researchers at the University of Sharjah are exploring a promising approach that could enhance the immune system’s ability to fight cancer, potentially paving the way for new treatments. In a recent ...

A new paper in the journal Nature reveals an astonishing—and frankly unsettling—feature of some cancer cells: the ability to physically inject mitochondria into their neighboring cells. These ...